Werewolf Therapeutics (NASDAQ:HOWL) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 2 | 0 | 0 | 0 |
Last 30D | 1 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 1 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $13.5, a high estimate of $15.00, and a low estimate of $12.00. A decline of 10.0% from the prior average price target is evident in the current average.
Analyzing Analyst Ratings: A Detailed Breakdown
A clear picture of Werewolf Therapeutics's...
Login or create a forever free account to read this news
Sign up/Log in